BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22975016)

  • 1. Screening for hyperglycemia in the developing world: rationale, challenges and opportunities.
    Echouffo-Tcheugui JB; Mayige M; Ogbera AO; Sobngwi E; Kengne AP
    Diabetes Res Clin Pract; 2012 Nov; 98(2):199-208. PubMed ID: 22975016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease in low-income to middle-income countries: the case for increased screening.
    George C; Mogueo A; Okpechi I; Echouffo-Tcheugui JB; Kengne AP
    BMJ Glob Health; 2017; 2(2):e000256. PubMed ID: 29081996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middle-income countries-a review of the current literature.
    George C; Echouffo-Tcheugui JB; Jaar BG; Okpechi IG; Kengne AP
    BMC Med; 2022 Aug; 20(1):247. PubMed ID: 35915501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.
    Davis A; Smith P; Ferguson M; Stephens D; Gianopoulos I
    Health Technol Assess; 2007 Oct; 11(42):1-294. PubMed ID: 17927921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
    Siegel KR; Ali MK; Zhou X; Ng BP; Jawanda S; Proia K; Zhang X; Gregg EW; Albright AL; Zhang P
    Diabetes Care; 2020 Jul; 43(7):1557-1592. PubMed ID: 33534729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for diabetes.
    Backholer K; Chen L; Shaw J
    Pathology; 2012 Feb; 44(2):110-4. PubMed ID: 22228253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing diabetes mellitus in developing countries.
    Echouffo-Tcheugui JB; Dagogo-Jack S
    Nat Rev Endocrinol; 2012 Sep; 8(9):557-62. PubMed ID: 22488646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations.
    Ekwunife OI; O'Mahony JF; Gerber Grote A; Mosch C; Paeck T; Lhachimi SK
    Pharmacoeconomics; 2017 Jan; 35(1):65-82. PubMed ID: 27637758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries.
    Wright CM; Boudarène L; Ha NT; Wu O; Hawkins N
    BMC Public Health; 2018 Mar; 18(1):373. PubMed ID: 29558894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation.
    Farrar D; Simmonds M; Griffin S; Duarte A; Lawlor DA; Sculpher M; Fairley L; Golder S; Tuffnell D; Bland M; Dunne F; Whitelaw D; Wright J; Sheldon TA
    Health Technol Assess; 2016 Nov; 20(86):1-348. PubMed ID: 27917777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
    Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
    PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of screening for diabetes and intermediate hyperglycaemia.
    Colagiuri S
    Diabetes Res Clin Pract; 2012 Sep; 97(3):341-2. PubMed ID: 22682947
    [No Abstract]   [Full Text] [Related]  

  • 13. Opportunities and challenges for introducing HPV testing for cervical cancer screening in sub-Saharan Africa.
    Tsu VD; Njama-Meya D; Lim J; Murray M; de Sanjose S
    Prev Med; 2018 Sep; 114():205-208. PubMed ID: 30031013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee.
    Waugh N; Royle P; Clar C; Henderson R; Cummins E; Hadden D; Lindsay R; Pearson D
    Health Technol Assess; 2010 Sep; 14(45):1-183. PubMed ID: 20868615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
    Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunity for breast cancer screening in limited resource countries: a literature review and implications for Iran.
    Asadzadeh VF; Broeders MJ; Kiemeney LA; Verbeek AL
    Asian Pac J Cancer Prev; 2011; 12(10):2467-75. PubMed ID: 22320940
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.